Brief: Akoya Biosciences sees FY revenue USD 95-98 million
08/05/2023 21:41
May 8 (Reuters) - Akoya Biosciences Outlook FY revenue USD 95-98 million. * Q1 EPS USD -0.49 * Q1 revenue USD 21.4 million * Q1 gross profit USD 12.3 million * Q1 gross margin 57.4%
Recent news on Akoya Biosciences
See all newsBrief: Akoya Biosciences Inc - On May 20, Receives Unsolicited Acquisition Proposal At $1.40 Per Share From A Third Party- SEC Filing
Akoya Biosciences Inc reports results for the quarter ended March 31 - Earnings Summary
Brief: Akoya Biosciences Q1 Gross Margin 59.3%
Akoya Biosciences Inc expected to post a loss of 20 cents a share - Earnings Preview
Leerink Partners downgrades Quanterix to 'market perform' on Akoya deal risks